Qiu et al., investigated the role of KDM6A loss in reshaping the epigenetic landscape of bladder cancer, showing that this mutation disrupts specific transcription factor circuits rather than inducing widespread epigenomic alterations—offering mechanistic insight into the epigenetically driven transformation of urothelial cells [30]. This evidence concerns the gene KDM6A and urinary bladder cancer.